Business Scope

Product Planning

• Market Research

  1. Securement of item through Domestic and Overseas Market Research
  2. Continuous Feasibility Study through Clinical Data
  3. Securement of feasible drug

• Approval Strategy

  1. Preparation of specialized Documnet in Korea and compliance monitoring
  2. Aggressive support for market exclusivity approval
  3. Finding solution for difficult approval

• Various API Supplier

  1. Securement of feasible API through the domestic and overseas Partner
  2. Securing new Supplier in the case of new Synthesis Planning
  3. Making new partner with non-infringing ingredient
  4. cGMP level / Q11 supportable

• Patent Strategy

  1. Development of early launching items through non-infringing
  2. Developing items for the patent-license linkage of Korea-US FTA
  3. Securement of avoiding ingredient and formulation

• Clinical Strategy

  1. Preview of the needs for clinical trials in Korea
  2. Preparation of clinical trials through CRO selection and IND approval
  3. Systematic Clinical Trials through CRO management

• Creativity

  1. Planning and Development Strategy for Newly Developed Item
  2. New Item Development through Domestic and Overseas Partnership
  3. Business diversification through New Business Model Development

Trading & Distribution

Klasia established infra in various countries through alliances. This enables us to develop the new business models.

License

Klasia has been proposed by domestic and overseas partners and proceeded new drugs, modified new drugs and first generic projects.